+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
SPECT & PET Radiopharmaceuticals Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
SPECT & PET Radiopharmaceuticals Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

SPECT & PET Radiopharmaceuticals Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6078753
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Crafting an Introduction to the SPECT & PET Radiopharmaceuticals Arena

The landscape of molecular imaging has evolved into a cornerstone of modern diagnostics, intertwining technological sophistication with clinical necessity. SPECT (Single-Photon Emission Computed Tomography) and PET (Positron Emission Tomography) radiopharmaceuticals deliver unparalleled insights into physiological and pathological processes, driving precision medicine forward. As demand for targeted diagnostics intensifies, these agents have become indispensable tools across cardiology, oncology, and neurology. Regulatory advancements, enhanced production capabilities, and collaborative research efforts have collectively elevated both efficacy and safety profiles. Stakeholders are now navigating a dynamic environment characterized by shifting reimbursement policies, cross-border trade complexities, and accelerating innovation. This executive summary distills key developments, segmentation insights, regional variations, and actionable strategies to empower decision-makers in leveraging growth opportunities, mitigating risks, and shaping a resilient, patient-centric future for SPECT and PET radiopharmaceutical applications.

Transformative Shifts Defining the Current Radiopharmaceuticals Landscape

Recent years have witnessed transformative shifts reshaping how radiopharmaceuticals integrate into clinical workflows. Convergence of hybrid imaging platforms-such as PET/CT and hybrid SPECT modalities-has redefined diagnostic accuracy by fusing anatomical detail with functional information. Advancements in radiochemistry have yielded next-generation tracers, including novel gallium-68 conjugates with enhanced receptor specificity, minimizing off-target binding and improving lesion detectability. Parallel developments in generator and cyclotron production models have accelerated supply chain resilience, reducing lead times and enabling decentralized manufacturing. Regulatory frameworks have adapted to fast-track approval pathways, encouraging public-private partnerships and incentivizing research in underserved indications. Furthermore, digital health solutions and artificial intelligence-driven analytics are now complementing image interpretation, promoting standardized quantification and workflow optimization. These converging trends underscore a paradigm shift from standalone imaging to integrated diagnostic ecosystems that deliver actionable intelligence and support personalized patient management.

Assessing the Cumulative Impact of United States Tariffs in 2025

The introduction of new tariffs on radiopharmaceutical imports scheduled for 2025 is poised to alter the competitive balance across global supply chains. Increased duties on precursor isotopes and finished agents may drive up production costs for suppliers relying on cross-border shipments, compelling a strategic reassessment of manufacturing footprints. Domestic producers could seize advantage by reinforcing local cyclotron networks, thereby insulating operations from tariff volatility. Concurrently, end users-hospitals, diagnostic centers, and research institutes-may encounter margin pressures as reimbursement codes struggle to keep pace with higher input costs. In response, collaborative purchasing consortia and bulk procurement agreements are emerging to negotiate more favorable terms. Meanwhile, regulatory bodies and industry associations are lobbying for tariff exemptions on critical medical isotopes to preserve patient access and avoid diagnostic delays. Ultimately, these shifts will test the agility of manufacturers and healthcare providers to adapt procurement strategies, optimize inventory management, and sustain the affordability of advanced imaging services.

Key Segmentation Insights Across Multiple Market Dimensions

A nuanced exploration of market segmentation reveals critical drivers underpinning growth trajectories. Based on type, gallium-based radiopharmaceuticals remain at the forefront, propelled by gallium-68 DOTATATE’s superior receptor targeting and gallium-67 citrate’s established role in infection imaging. Iodine-based tracers, including iodine-123 and iodine-131 capsules, sustain demand through thyroid diagnostics and therapeutic applications, while technetium-based agents such as sodium pertechnetate and technetium-sestamibi continue to dominate perfusion studies. Application-driven segmentation highlights oncology as the largest contributor, leveraging cancer staging and tumor detection capabilities, followed by cardiology with myocardial perfusion imaging and viability assessments, and neurology focusing on brain perfusion imaging and dementia diagnostics. End users span academic and research institutes-both independent and university-based-alongside ambulatory surgical centers, diagnostic imaging centers, and hospitals differentiated by ownership models. Disease indication analysis underscores cancer subtypes, cardiovascular diseases like coronary artery disease, and neurological disorders including Alzheimer’s disease and epilepsy. Source segmentation illustrates varied production models, from cyclotron-based centralized and local units to generator-produced hospital and mobile solutions, extending to nuclear reactor-produced isotopes from academic and government reactors. Finally, instrumentation categories reveal an ongoing transition to hybrid systems: gamma cameras evolving into dual-head designs, PET converging with CT and MRI modalities, and SPECT adopting hybrid and standalone configurations to meet diverse clinical requirements.

Uncovering Key Regional Insights Shaping Market Growth

Geographical dynamics display significant heterogeneity in adoption rates and investment priorities. In the Americas, robust reimbursement structures and advanced clinical infrastructure underpin high utilization of PET/CT suites, while ongoing expansion of cyclotron networks facilitates local tracer production. Meanwhile, Europe, Middle East & Africa demonstrates pronounced public-private collaborations, with regulatory harmonization efforts accelerating tracer approvals, particularly for gallium-based compounds. In the Asia-Pacific region, rapid growth is driven by increasing healthcare expenditures, growing prevalence of chronic diseases, and government initiatives aimed at enhancing nuclear medicine capabilities; emerging markets in Southeast Asia invest heavily in mobile generator units to bridge access gaps. Cross-regional partnerships are gaining momentum, enabling technology transfer and joint clinical trials, which in turn contribute to a more balanced global ecosystem. These regional nuances inform strategic decisions on capacity planning, investment allocation, and market entry approaches for both established players and new entrants.

Profiling Key Companies Driving Innovation and Competition

The competitive landscape is anchored by established industry leaders and innovative challengers alike. Advanced Accelerator Applications, a Novartis company, commands attention with its comprehensive portfolio of gallium-based diagnostics, while Blue Earth Diagnostics leverages targeted PSMA imaging to penetrate prostate cancer markets. Bracco Imaging S.p.A. maintains a stronghold in iodine-based formulations and gamma camera enhancements. Cardinal Health Nuclear & Precision Health Solutions and Curium Pharma consolidate market share through extensive distribution networks and proprietary therapies. Eckert & Ziegler Radiopharma GmbH excels in generator-produced isotopes, whereas GE Healthcare and Siemens Healthineers drive hybrid instrumentation sales backed by integrated software ecosystems. IBA Molecular and ITM Isotope Technologies Munich SE advance cyclotron production capabilities, supporting decentralized manufacturing models. Immunomedics, Inc. and Jubilant Radiopharma focus on novel tracer development for niche indications, and Lantheus Holdings, Inc. continues to optimize technetium-based agents. Norgine B.V. expands its reactor-produced isotope offerings, while SOFIE Biosciences pioneers mobile generator innovations that enhance point-of-care delivery. Together, these companies shape a dynamic market characterized by strategic partnerships, mergers and acquisitions, and relentless innovation.

Actionable Recommendations for Industry Leaders to Secure Competitive Advantage

Industry leaders should prioritize strengthening localized production infrastructures to mitigate supply disruptions and tariff exposure. Investing in hybrid imaging platforms and AI-driven analytics will enhance diagnostic accuracy and workflow efficiency, positioning organizations at the forefront of precision medicine. Cultivating strategic alliances with academic and government research institutions can accelerate tracer development, unlocking novel applications across oncology, cardiology, and neurology. Negotiating long-term procurement agreements and exploring public policy advocacy for tariff relief will safeguard cost structures and ensure patient access. Additionally, implementing comprehensive training programs for nuclear medicine personnel will optimize utilization rates and support the integration of emerging technologies. Finally, adopting sustainable practices-from waste management protocols to energy-efficient cyclotron operations-will address regulatory scrutiny and bolster corporate responsibility initiatives.

Concluding Perspectives on Navigating the Evolving Radiopharmaceuticals Market

In summary, the SPECT and PET radiopharmaceuticals market stands at a pivotal juncture, shaped by technological breakthroughs, regulatory evolution, and evolving trade policies. A holistic approach that integrates localized production, advanced instrumentation, and strategic collaborations will enable stakeholders to navigate complexities while delivering superior clinical outcomes. Embracing digital transformation and fostering an innovation-centric culture will further drive differentiation and sustainable growth. As the field progresses, maintaining a patient-centric focus and proactive engagement with policymakers will ensure that the potential of molecular imaging continues to expand, ultimately enhancing diagnostic precision and therapeutic pathways across diverse healthcare contexts.

Market Segmentation & Coverage

This research report categorizes the SPECT & PET Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Gallium-Based Radiopharmaceuticals
    • Gallium-67 Citrate
    • Gallium-68 DOTATATE
  • Iodine-Based Radiopharmaceuticals
    • Iodine-123 Capsules
    • Iodine-131 Capsules
  • Technetium-Based Radiopharmaceuticals
    • Sodium Pertechnetate
    • Technetium-Sestamibi
    • Technetium-Tetrofosmin
  • Cardiology
    • Cardiac Viability Assessment
    • Myocardial Perfusion Imaging
  • Neurology
    • Brain Perfusion Imaging
    • Dementia Diagnostics
  • Oncology
    • Cancer Staging
    • Tumor Detection
  • Academic & Research Institutes
    • Independent Research Institutions
    • University-Based
  • Ambulatory Surgical Centers
    • Freestanding Centers
    • Integrated Centers
  • Diagnostic Imaging Centers
    • Independent Centers
    • Network-Based Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Cancer
    • Breast Cancer
    • Lung Cancer
    • Prostate Cancer
  • Cardiovascular Diseases
    • Coronary Artery Disease
    • Heart Failure
  • Neurological Disorders
    • Alzheimer's Disease
    • Epilepsy
  • Cyclotron Produced
    • Centralized Production Units
    • Local Production Units
  • Generator Produced
    • Hospital Units
    • Mobile Units
  • Nuclear Reactor Produced
    • Academic Reactors
    • Government Reactors
  • Gamma Cameras
    • Dual-Head Cameras
    • Single-Head Cameras
  • Positron Emission Tomography (PET)
    • Hybrid PET/CT
    • Hybrid PET/MRI
  • Single-Photon Emission Computed Tomography (SPET)
    • Hybrid SPET
    • Standalone SPET

This research report categorizes the SPECT & PET Radiopharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the SPECT & PET Radiopharmaceuticals Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Advanced Accelerator Applications, a Novartis Company
  • Blue Earth Diagnostics
  • Bracco Imaging S.p.A.
  • Cardinal Health Nuclear & Precision Health Solutions
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • GE Healthcare
  • IBA Molecular
  • Immunomedics, Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Norgine B.V.
  • Siemens Healthineers
  • SOFIE Biosciences

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. SPECT & PET Radiopharmaceuticals Market, by Type
8.1. Introduction
8.2. Gallium-Based Radiopharmaceuticals
8.2.1. Gallium-67 Citrate
8.2.2. Gallium-68 DOTATATE
8.3. Iodine-Based Radiopharmaceuticals
8.3.1. Iodine-123 Capsules
8.3.2. Iodine-131 Capsules
8.4. Technetium-Based Radiopharmaceuticals
8.4.1. Sodium Pertechnetate
8.4.2. Technetium-Sestamibi
8.4.3. Technetium-Tetrofosmin
9. SPECT & PET Radiopharmaceuticals Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Cardiac Viability Assessment
9.2.2. Myocardial Perfusion Imaging
9.3. Neurology
9.3.1. Brain Perfusion Imaging
9.3.2. Dementia Diagnostics
9.4. Oncology
9.4.1. Cancer Staging
9.4.2. Tumor Detection
10. SPECT & PET Radiopharmaceuticals Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.2.1. Independent Research Institutions
10.2.2. University-Based
10.3. Ambulatory Surgical Centers
10.3.1. Freestanding Centers
10.3.2. Integrated Centers
10.4. Diagnostic Imaging Centers
10.4.1. Independent Centers
10.4.2. Network-Based Centers
10.5. Hospitals
10.5.1. Private Hospitals
10.5.2. Public Hospitals
11. SPECT & PET Radiopharmaceuticals Market, by Disease Indication
11.1. Introduction
11.2. Cancer
11.2.1. Breast Cancer
11.2.2. Lung Cancer
11.2.3. Prostate Cancer
11.3. Cardiovascular Diseases
11.3.1. Coronary Artery Disease
11.3.2. Heart Failure
11.4. Neurological Disorders
11.4.1. Alzheimer's Disease
11.4.2. Epilepsy
12. SPECT & PET Radiopharmaceuticals Market, by Source
12.1. Introduction
12.2. Cyclotron Produced
12.2.1. Centralized Production Units
12.2.2. Local Production Units
12.3. Generator Produced
12.3.1. Hospital Units
12.3.2. Mobile Units
12.4. Nuclear Reactor Produced
12.4.1. Academic Reactors
12.4.2. Government Reactors
13. SPECT & PET Radiopharmaceuticals Market, by Instrumentation
13.1. Introduction
13.2. Gamma Cameras
13.2.1. Dual-Head Cameras
13.2.2. Single-Head Cameras
13.3. Positron Emission Tomography (PET)
13.3.1. Hybrid PET/CT
13.3.2. Hybrid PET/MRI
13.4. Single-Photon Emission Computed Tomography (SPET)
13.4.1. Hybrid SPET
13.4.2. Standalone SPET
14. Americas SPECT & PET Radiopharmaceuticals Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific SPECT & PET Radiopharmaceuticals Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa SPECT & PET Radiopharmaceuticals Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Advanced Accelerator Applications, a Novartis Company
17.3.2. Blue Earth Diagnostics
17.3.3. Bracco Imaging S.p.A.
17.3.4. Cardinal Health Nuclear & Precision Health Solutions
17.3.5. Curium Pharma
17.3.6. Eckert & Ziegler Radiopharma GmbH
17.3.7. GE Healthcare
17.3.8. IBA Molecular
17.3.9. Immunomedics, Inc.
17.3.10. ITM Isotope Technologies Munich SE
17.3.11. Jubilant Radiopharma
17.3.12. Lantheus Holdings, Inc.
17.3.13. Norgine B.V.
17.3.14. Siemens Healthineers
17.3.15. SOFIE Biosciences
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. SPECT & PET RADIOPHARMACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. SPECT & PET RADIOPHARMACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. SPECT & PET RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2024 VS 2030 (%)
FIGURE 18. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. SPECT & PET RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. SPECT & PET RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SPECT & PET RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-67 CITRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68 DOTATATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-123 CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131 CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SODIUM PERTECHNETATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-SESTAMIBI, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-TETROFOSMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIAC VIABILITY ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MYOCARDIAL PERFUSION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY BRAIN PERFUSION IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DEMENTIA DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER STAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TUMOR DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDEPENDENT RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY UNIVERSITY-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INTEGRATED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NETWORK-BASED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CENTRALIZED PRODUCTION UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY LOCAL PRODUCTION UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITAL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY MOBILE UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC REACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GOVERNMENT REACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DUAL-HEAD CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-HEAD CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HYBRID PET/CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HYBRID PET/MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HYBRID SPET, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY STANDALONE SPET, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 114. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 115. AMERICAS SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 165. BRAZIL SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 166. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 168. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 169. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 172. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 173. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 174. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 176. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 177. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 178. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 180. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 181. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 182. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 184. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 185. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 186. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 187. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 188. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 189. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 190. CANADA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 191. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 205. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 206. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 207. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 209. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 210. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 211. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 212. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 213. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 215. MEXICO SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON PRODUCED, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NUCLEAR REACTOR PRODUCED, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY INSTRUMENTATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GAMMA CAMERAS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY (PET), 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPET), 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-BASED RADIOPHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA SPECT & PET RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA SPECT & PET

Companies Mentioned

  • Advanced Accelerator Applications, a Novartis Company
  • Blue Earth Diagnostics
  • Bracco Imaging S.p.A.
  • Cardinal Health Nuclear & Precision Health Solutions
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • GE Healthcare
  • IBA Molecular
  • Immunomedics, Inc.
  • ITM Isotope Technologies Munich SE
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Norgine B.V.
  • Siemens Healthineers
  • SOFIE Biosciences

Methodology

Loading
LOADING...

Related Topics

Related Reports

Radiopharmaceuticals Market by Type, Procedural Volume, Application - Global Forecast 2025-2030 - Product Image

Radiopharmaceuticals Market by Type, Procedural Volume, Application - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Nuclear Imaging Equipment Market by Product, Radiopharmaceuticals, Application, End-User - Global Forecast 2025-2030 - Product Image

Nuclear Imaging Equipment Market by Product, Radiopharmaceuticals, Application, End-User - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Radiopharmaceuticals - Global Strategic Business Report - Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • 739 Pages
  • Global
From
United States Computed Tomography - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

United States Computed Tomography - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 92 Pages
  • United States
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.